Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models RY Mekky, N El-Ekiaby, SA El Sobky, NM Elemam, RA Youness, ... Archives of virology 164, 1587-1595, 2019 | 32 | 2019 |
Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV SA El Sobky, NM El-Ekiaby, RY Mekky, NM Elemam, MAM Eldin, ... Immunology Letters 169, 52-60, 2016 | 21 | 2016 |
Repressing PU. 1 by miR-29a∗ in NK cells of HCV patients, diminishes its cytolytic effect on HCV infected cell models NM Elemam, RY Mekky, NM El-Ekiaby, SA El Sobky, MAM El Din, ... Human Immunology 76 (9), 687-694, 2015 | 15 | 2015 |
Epigenetic harnessing of HCV via modulating the lipid droplet-protein, TIP47, in HCV cell models NM El-Ekiaby, RY Mekky, SA El Sobky, NM Elemam, M El-Sayed, ... FEBS letters 589 (17), 2266-2273, 2015 | 7 | 2015 |
Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC DA Habashy, MHM Hamad, M Ragheb, ZA Khalil, SA El Sobky, KA Hosny, ... Life Sciences 310, 121075, 2022 | 3 | 2022 |
Regulation of lipid droplet (LD) formation in hepatocytes via regulation of SREBP1c by non-coding RNAs SA El Sobky, NK Aboud, NM El Assaly, IO Fawzy, N El-Ekiaby, ... Frontiers in Medicine 9, 903856, 2022 | 3 | 2022 |
P166 A COACH, A PLAYMAKER, A DEFENDER AND STRIKERS: AN EPIGENETIC-TARGET INTERPLAY IN HCV/HCC MM Fouad, NM Elemam, HB Sherif, SA El Sobky, RA Yacoub, ... Journal of Hepatology 60 (1), S121-S122, 2014 | | 2014 |